Bloomberg | May 7, 2021
Relaxing IP restrictions would certainly help over the long term, but many nations need vaccines now, said Lawrence Gostin, director of the O’Neill Institute for National and Global Health Law at Georgetown. Countries should be given both immediate supplies and the ability to manufacture that the patent waiver would provide, he said.